RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
159 hedge funds and large institutions have $706M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 39 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
159
Holders Change
+13
Holders Change %
+8.9%
% of All Funds
2.75%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
36
Increased
39
Reduced
47
Closed
23
Calls
$46M
Puts
$28.1M
Net Calls
+$17.9M
Net Calls Change
+$12.8M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$45.5M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$26.5M |
| 3 |
GTC
Ghost Tree Capital
New York
|
+$18.2M |
| 4 |
FAM
Fred Alger Management
New York
|
+$15.4M |
| 5 |
Millennium Management
New York
|
+$11.8M |
